Download as pdf or txt
Download as pdf or txt
You are on page 1of 4

Equities Market Commentary

Anglo American Platinum Recommendation: BUY


Target Price: R 1800.00
Initiating report
*Stock ratings are relative to the relevant country benchmark.
Positioned for the long term ¹Target price is for 12 months

09 December 2020
This report is intended for the exclusive use of the recipient and may not be distributed to any
other person without SBG Securities' express written consent.
 Initiating coverage: Buy, target price R1,800: We initiate coverage on Anglo American Platinum
(Amplats) with a Buy recommendation and target price of R1,800 (TR: 70%). Amplats represents a
defensive play on PGMs relative to peers, with modest low-cost growth prospects and long-life assets
favouring platinum. The balance sheet is expected to become materially cash flush within 12 months,
which should allow for special dividends and new growth opportunities. However, recent processing
disruptions place Amplat’s ability to sell metal at higher risk for FY21E.

 Opportunities and risks lie with two operations: Mogalakwena and Amandelbult dominate group
production at over 70%, although they are located at opposite ends of the company cost curve. In
addition, Amandelbult is three times more exposed to rhodium and 40% more exposed to platinum
than Mogalakwena. Amplats group revenue is most exposed to rhodium (40%), more so than Impala
(35%), assuming spot prices. We think rhodium could trend higher and we also think platinum will
become more in vogue in the long term. However, Amandelbult is mostly high cost, adopting labour-
intensive conventional mining practices, whereas Mogalakwena is low technical risk mechanised.
Hence, both mines are important, and both will, in our view, require more reinvestment. We find that
although Amplats has lower unit cash operating costs compared to Impala, the two companies have
very similar all-in costs due to higher capex intensity, and corporate and marketing costs. Capex
intensity is likely to rise, but cost culture is unlikely to change.

 Catalysts/risks: We expect sales to be ahead of guidance based on our estimates, by some 150 -
200koz 6E. However, unsold inventory will be sold in FY21E. Investors should also be aware that
issues at ACP will only have a temporary effect on supply, but nevertheless could impact prices
Share data
materially in the short term. Although ACP Phase A has been rebuilt, Phase B is scheduled for a large
rebuild that may take as long as 12 months. Hence, there will be no redundancy in place should Phase RIC AMSJ.J
A need to be shuttered, presenting material risk to production and supply. Any interruption to Phase
B is also likely to result in another force majeure, which impacts Amplats’ purchase of concentrate Sub industry Platinum & Precious Metals
(POC) and toll customers. We also expect capex to rise materially to about R9bn in FY21E.
Price (04 Dec 2020) R 1,192
 Peak earnings in FY21E: We expect FY20E sales of approximately 2.65moz vs guidance of 2.5moz Market cap. (R m) 315,880
on expectations of an early start on Phase A at ACP allowing for an additional month of refined
Enterprise value (R m) 319,501
production. We expect all-in costs (SBGS metric) to average R18,391/oz in FY20E (vs basket price
of R34,500/oz at spot prices), rising to R19,894/oz in FY21E (vs basket price of R38,000/oz Market cap. (USD m) 20,763
assuming spot prices). The increase in all-in costs is driven by higher capex and royalties. We estimate Enterprise value (USD m) 20,107
FY20E HEPS at R80/s, rising to R269 in FY21E. We are cautious on FY20E special dividends (R25/s Avg. daily trade value (USD m) 23
vs R50/s if it were not for the issues at ACP).
Free float (%) 14
 Valuation: We estimate Anglo Platinum could be worth R1,800 to R1,900/s using a DCF
methodology and our 12-month average outlook for prices. We expect that earnings delivery Price relative to FTSE/JSE All Share
following the recent rally in prices, increases in dividends and strengthening balance sheet could help 1600

re-rate the stock to at least 5x EV/EBITDA, yielding an upside valuation of about R2,000/s. 1400
1200
1000
800
600
400
12/19 3/20 6/20 9/20
Key forecasts Dec 17A Dec 18A Dec 19A Dec 20E Dec 21E Dec 22E
Average Rand/Dollar (x) 13.33 14.50 16.65 15.50 15.81 Price FTSE/JSE All Share (rebased)
Palladium price (USD/oz) 1,029 1,518 2,198 2,400 2,500
Platinum price (USD/oz) 871 861 876 1,000 1,000 Historical performance relative to FTSE/JSE All Share (%)
Rhodium price (USD/oz) 2,204 3,808 10,829 18,500 20,000 Performance over 1M 3M 12M
Diluted headline EPS (reported) 14.84 28.93 70.87 80.19 268.74 240.83 Absolute (%) 5.0 -3.4 -5.2
EBITDA (R m) 11,985 14,503 29,950 34,547 99,369 92,010
Relative (%) -2.6 -13.7 -13.7
EV/EBITDA 7.1 9.6 10.9 8.9 2.9 3.3 Source: FTSE/JSE All Share, SBG Securities Research
Net cash (debt) 9,019 2,891 17,278 10,123 57,244 84,336 The price relative chart measures performance against the
Free cash flow (8,133) 8,018 19,691 3,078 77,585 64,684 South Africa FTSE/JSE All Share which closed at 59419 on
04 Dec 2020
DPS - ordinary 343.64 11.25 27.60 32.08 107.50 96.33
Source: Company financials, SBG Securities estimates

Equities Research provided by SBG Securities (Pty) Limited


9 December 2020

Disclaimer
The SBG Securities Proprietary Limited’s (“SBG Sec”) report (“Report”) is not directed to, or intended for
distribution to or use by, any person or entity who is a citizen or resident of or located in any locality, state,
country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or
regulation or which would subject SBG Sec to any registration or licensing requirement within such jurisdiction.
All material presented in the Report, unless specifically indicated otherwise, is under copyright to SBG Sec.
None of the material, nor its content, nor any copy of it, may be altered in any way, transmitted to, copied or
distributed to any other party, without the prior express written permission of SBG Sec. All trademarks, service
marks and logos used in the Report are trademarks or service marks or registered trademarks or service marks
of SBG Sec or its affiliates.

The Report does not constitute an offer or the solicitation of an offer for the sale or purchase of any securities
as discussed therein or at all. While every care has been taken in preparing the Report, no representation,
warranty or undertaking (express or implied) is given and neither responsibility nor liability is accepted by any
member of the Standard Bank Group Limited (“SB Group”), its employees and agents, as to the accuracy of
the information contained herein. No member of the SB Group, including but not limited to SBG Sec, shall be
held liable for the use of and reliance on the opinions, estimates and findings.

SBG Sec, the SB Group and its subsidiaries and directors and employees of these companies may from time
to time have long or short positions in the securities mentioned in the Report and may add to or dispose of such
securities at their discretion without notice.

SBG Sec accepts no liability for loss arising from the use of the material presented in the Report, except that
this exclusion of liability does not apply to the extent that liability arises under specific statutes or regulations
applicable to SBG Sec. The Report is not to be relied upon in substitution for the exercise of independent
judgment. SBG Sec may have issued, and may in the future issue, a trading call regarding the securities. In
addition, SBG Sec may have issued, and may in the future issue, other reports that are inconsistent with, and
reach different conclusions from, the information presented in the Report. Those reports reflect the different
assumptions, views and analytical methods of the analysts who prepared them and SBG Sec is under no
obligation to ensure that such other reports are brought to the attention of any recipient of the Report.

Protection of Personal Information Consent


Standard Bank Group, its subsidiaries and associate companies (SBG Securities) have committed to treat the
personal information that it collects as private and confidential and has published a comprehensive privacy
statement accessible on this link. Should you wish to withdraw your consent to the processing of your personal
information kindly email ResearchCompliance@standardbank.co.za

Client: means, for the purpose of this section, any natural or juristic person acting through their duly authorise
representative(s), who has subscribed to or consented to being subscribed
to receiving research Services
Personal Information: means information relating to an identifiable, natural or juristic person,
including information relating to race, gender, sex, marital status,
nationality, ethnic or social origin, colour, sexual orientation, age, physical
or mental health, religion, belief, disability, language, birth, education,
identity number, telephone number, email, postal or street address,
biometric information and financial, criminal or employment history as well
as correspondence sent by the person that is implicitly or explicitly of a
private or confidential nature or further correspondence that would reveal
the contents of the original correspondence.
Process: means any operation or activity, whether automated or not, concerning
Personal Information, including collection, receipt, recording, organisation,
collation, storage, updating, modification, retrieval, alteration, consultation,
use, dissemination (whether by means of transmission, distribution or
making available in any form), merging, linking, blocking, degradation,
erasure or destruction.
Research Reports: means investment research reports, in relation to the Services, prepared
by an independent research analyst, non-independent research analyst or
strategist who is part of an investment research team in a stock brokerage,
global markets desk or corporate and investment bank environment.
Services: means, inter alia, the provision of the Research Reports and other
communications and events with respect to equities, market strategy,
companies, industries, commodities and countries and associated sales
and trading commentary by SBG Securities

Equity Research 2
9 December 2020

Consent for Processing Personal Information

The Client acknowledges that:


1 Applicable law may at times require SBG Sec to collect the Client’s Personal Information;
2 Personal Information may be collected from public sources;
3 SBG Sec may be unable to fulfil its regulatory obligations and provide Services to the Client without
Processing the Client’s Personal Information;
4 All Personal Information which the Client provides to SBG Sec is voluntarily provided;
5 SBG Sec shall determine the Services and means of Processing any Personal Information that is provided
by the Client;
6 Personal Information may be processed by SBG Sec and/ or, The Standard Bank of South Africa Limited
and/or its associated entities or duly authorised third-party service providers.
7 The Client consents to SBG Sec processing its Personal Information in order to:
7.1 create and administer the Client’s profile as contemplated by regulation;
7.2 carry out statistical and other analysis to identify potential markets and trends;
7.3 develop new products and services; and/or
7.4 any other purpose SBG Sec reasonably believe is required to fulfil its obligations in accordance with
regulation or this agreement.
8 The Client has consented to the Processing of its Personal Information for the purpose of clause 7 above.
9 The Client hereby expressly consents that SBG Sec may disclose to or share its Personal Information with
duly authorised third parties, which may be located in the Republic of South Africa or other jurisdictions,
where it is necessary in order for SBG Sec to fulfil its obligations in accordance with the regulation and/or this
agreement.
10 SBG Sec will require any third-party service providers to whom the Client’s Personal Information is
provided to agree to SBG Sec' data privacy principles policy and practices in accordance with the prevailing
regulations including data privacy laws.
The report is made available to South African retail investors only.

The report is distributed for information purposes only.

Stock ratings are defined as follows*:


Buy (B): The stock’s total return* is expected to be more than 20% (or more, depending on perceived risk)
over the next 12 months.
Hold (H): The stock’s total return is expected to be in the range of 10-20% over the next 12 months.
Sell (S): The stock’s total return is expected to be less than 10% over the next 12 months.
Restricted (R): In certain circumstances, Standard Bank Group policy and/or applicable law and regulations
preclude certain types of communications, including an investment recommendation, during the course of
SBG Securities' and/or Standard Banks Group's engagement in an investment banking transaction and in
certain other circumstances.
Rating suspended: The recommendation, target price or both have been suspended temporarily due to
market events that made coverage impracticable or to comply with applicable regulations and/or firm policies
in certain circumstances.
Speculative Buy (SBuy): SBG Securities may issue a "Speculative Buy" when the Analyst covering the
Company is of the view that the risk/reward trade-off is somewhat less compelling than that of a BUY rating.
These companies tend to have very high upside potential, but also a great degree of risk or uncertainty with
regard to future financial results.
Relative Three Month Ratings: SBG Securities may also assign a three-month relative call (or rating) to a
stock to highlight expected out-performance (most preferred) or under-performance (least preferred) versus
the geographic and industry sector over a three (3) month period. The relative call may highlight a specific
near-term catalyst or event impacting the Company or the market that is anticipated to have a short term price
impact on the equity securities of the Company. Absent any specific catalyst the analyst(s) will indicate the
most and least preferred stocks in the universe of stocks under coverage, explaining the basis for this short
term view. This three month view may be different from and does not affect a stocks` fundamental equity
rating, which reflects a longer-term total absolute return expectation.
Coverage weightings versus relevant broad market bench:
Overweight: Industry expected to outperform the relevant broad market benchmark over the next 12 months.
Market Weight: Industry expected to perform in-line with the relevant broad market benchmark over the next
12 months .
Underweight: Industry expected to underperform the relevant broad market benchmark over the next 12
months.

The recipients of the Report are urged to seek independent advice with regard to investing in securities (whether
such securities are referred to in the Report or generally).

Please note that the Report was originally prepared and issued by SBG Sec for distribution to its market
professional and institutional investor clients. The Report is specifically targeted towards such clients. The
securities discussed therein may involve a high degree of risk or volatility and may be intended for sale only to
investors with an understanding and capacity to assume the risks involved in investing in such securities.
Further it should be noted that:

• the report is not investment advice


• there are intrinsic risks involved in the buying and selling of securities;

Equity Research 3
9 December 2020

• there is no guarantee for the return of the full investment amount;


• any forecasts contained in the Report is based on hypothetical data are not guaranteed and are for
illustrative purposes only;
• returns may vary as a result of their dependence on a number of variable market factors;
• past performance is not necessarily indicative of future performance;
• as a financial needs analysis has not been conducted to assess the appropriateness of investing in
the securities mentioned in the Report or generally, investment or structure to your unique particular
circumstances, you are cautioned that there may be limitations on the appropriateness of the
information for your purposes and you should take particular care to consider the implications of
entering into a particular transaction, either on your own or with the assistance of an investment
professional;
• there may be various tax, accounting and legal implications to consider when investing in securities
and you must be aware of these implications before investing. In particular, SBG Sec does not
accept liability for the tax treatment by any court or by any authorities in any jurisdiction in relation
to any transaction based on the information. It is strongly recommended that professional advice be
sought before entering into any transaction involving the securities as discussed herein;
• the price, value of and income from any of the securities mentioned in the Report can fall as well as
rise. The value of securities and financial instruments are subject to exchange rate fluctuations that
may have a positive or adverse effect on the price or income of such securities or financial
instruments.

Please note that research analyst(s) who prepared the Report is/are not authorised to give investment advice
and would not be in a position to discuss the contents of the Report with any retail investor.

The Report may provide the addresses of, or contain hyperlinks to, websites. Except to the extent to which the
Report refers to website material of SBG Sec and SB Group, SBG Sec has not reviewed the linked site and
takes no responsibility for the content contained therein. Such address or hyperlink (including addresses or
hyperlinks to SBG Sec or SB Group’s own website material) is provided solely for your convenience and
information and the content of the linked site does not in any way form part of the Report. Accessing such
website or following such link through the Report shall be at your own risk.

By accepting the Report, you agree to be bound by the foregoing terms and limitations.

If you have any questions relating to the report contact SBG Sec.

Equity Research 4

You might also like